Newcastle-based drug discovery partner Newcells Biotech has appointed Emile Shaffu as Director of Sales. This strategic move aims to strengthen the company’s global market presence and enhance customer support in the field of in vitro models and bespoke assay services.

Medix Biochemica, a leading provider of in vitro diagnostics (IVD) raw materials, has announced the appointment of Lonnie Shoff to its Board of Directors. Shoff, formerly the President of the Clinical Diagnostics Division at Thermo Fisher Scientific, brings over 30 years of international healthcare experience to the role.

In a groundbreaking move towards accelerating pandemic response capabilities, Touchlight and LenioBio have announced a strategic partnership that could potentially transform the landscape of protein therapeutics development. This collaboration brings together two cutting-edge technologies in a bid to dramatically reduce the time required for vaccine production.

London-based startup Briefly Bio has launched with £1.2 million in pre-seed funding to tackle one of the most pressing issues in scientific research: reproducibility. With an estimated 50% of preclinical research experiments failing to be reproduced, costing the industry over £50 billion annually, Briefly Bio aims to revolutionise how scientists document and share their work.

Technological partnerships The expansion features Cytiva’s Xcellerex XDR Bioreactor single-use system. Silke Fetzer-Rümpler, Senior Vice President, Commercial at Cytiva, noted the system’s scalability and potential to accelerate clinical and commercial milestones.